AzTrials
AzTrials

Fear of ChildbirthNCT07263750

Effect of Haptonomy on Prenatal Attachment and Fear of Childbirth in Primiparous Couples

A study testing Haptonomy in people with Fear of Childbirth and Prenatal Attachment, run by Nigde Omer Halisdemir University at 1 site in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study was planned to evaluate the effect of haptonomy practice for primiparous pregnant women and their partners on prenatal attachment and fear of childbirth. Read more about this study

Who is it for?
Ages 19 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Fear of Childbirth, Prenatal Attachment
What is being tested?
Haptonomy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
144 participants
Where
1 siteTurkey (Türkiye)
Study dates
26 Mar 2025to 1 Apr 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • • At least a primary school graduate
  • Between the 24th and 26th weeks of pregnancy
  • According to calculations made by ultrasound based on the last menstrual period or, for pregnant women who do not know their last menstrual period, between the 24th and 26th weeks of pregnancy
  • Primiparous
  • No history of abortion/curettage
  • Planned/desired pregnancy
Show all 15Show fewer
  • Desired baby gender
  • Living with spouse
  • Attended pregnancy classes
  • Able to use technology such as computers and mobile phones to watch videos
  • No barriers to understanding questions and responding
  • No previous training on fear of childbirth or prenatal bonding
  • Not having previously received education on haptonomy or practised haptonomy
  • Not undergoing infertility treatment
  • Being between the ages of 19 and 35

Who cannot join

  • • Be at least 26 weeks pregnant
  • Live separately from spouse
  • Have an unplanned/unwanted pregnancy
  • Not want the baby to be of a specific gender
  • Not use technology
  • Be a high-risk pregnancy
Show all 9Show fewer
  • Have previously received training on fear of childbirth and prenatal bonding
  • Having previously received training in haptonomy and practised haptonomy
  • Deciding to discontinue haptonomy practice after the study began and/or giving birth prematurely before completing the practice sessions

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nilüfer Tuğut, Prof. Dr. contact

+0905327754828

nlfrtugut@gmail.com

sibel dilmen, lectuer contact

+905532628295

dilmensibel51@gmail.com

Turkey (Türkiye)1 site, 1 recruiting
  • Sivas Cumhuriyet University

    Merkez, Sivas, 58000

    Nilüfer Tugut, Prof.Dr., +0905327754828, nlfrtugut@gmail.com

    sibel dilmen, lectuer, 05532628295, dilmensibel51@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: The Effect of Haptonomy Application for Primiparous Pregnant Women and Their Partners on Prenatal Attachment and Fear of Childbirth: A Randomized Controlled Study

This study was planned to evaluate the effect of haptonomy practice for primiparous pregnant women and their partners on prenatal attachment and fear of childbirth.

Read the detailed description

Aim: This study was designed to evaluate the effect of haptonomy practice for primiparous pregnant women and their partners on prenatal attachment and fear of childbirth.

Methods: This randomized controlled experimental study will include primiparous pregnant women and their partners (36 couples in the experimental group and 36 couples in the control group) who apply to the childbirth education class of a public hospital in Turkey and are between 24-26 weeks of gestation.

The experimental group will receive haptonomy education in the childbirth class. Afterwards, a video-based haptonomy program will be delivered via e-mail or WhatsApp. Couples will be asked to perform haptonomy exercises once a week for 40 minutes over five weeks. No intervention will be applied to the control group.

Data will be collected before the intervention and at the end of the fifth week using the Personal Information Form, Prenatal Attachment Inventory (PAI), Wijma Delivery Expectancy/Experience Questionnaire Version A (W-DEQ A), Paternal-Fetal Attachment Scale (PFAS), and Fathers' Fear of Childbirth Scale (FFOC).

Data analysis will include frequency and percentage distributions, chi-square test, t-test, Mann-Whitney U test, repeated measures analysis, two-way ANOVA, Friedman test, and Cohen's d test.

Being tested
Haptonomy
Keywords
fear of childbirth, pregnant, father, prenatal attachment, haptonomia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HaptonomyBehavioural

    Also called Haptonomy, as a field dealing with emotional contact through touch, describe the relationship between parents and the unborn baby.

    Since there are no studies in the literature evaluating the effect of planned video modelling haptonomy on prenatal bonding and fear of childbirth in expectant mothers and fathers, it is believed that the results obtained from this study will contribute significantly to the literature by guiding and shedding light on future studies.

Study groups in NCT07263750
Study groupRoleWhat they receive
experimental groupExperimentalHaptonomy training will be provided to the experimental group within the childbirth class. Afterwards, the video-based haptonomy program will be sent via e-mail or WhatsApp. Couples will be asked to practice haptonomy exercises for five weeks, one 40-minute session per week.
Receives: Behavioral: Haptonomy
control groupNo interventionStandard of care Group The control group will not receive any treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prenatal Attachment Inventory (PAI)

    The PAI is a validated, explain thoughts, feelings, and situations experienced by woman during pregnancy and to determine the level of attachment to infant in prenatal period. Each item is of a four-point Likert type, with a score between 1 and 4. A minimum score of 21 and a maximum score of 84 can be obtained from the scale. Increase in the score obtained by pregnant indicates that level of attachment also increases.

    Measured: Baseline

  2. Wijma Delivery Expectancy/Experience Questionnaire version A (W-DEQ-A)

    The W-DEQ-A is a validated,to determine the level of birth fear experienced by pregnant women.Answers in the scale are numbered from 0 to 5 and are in a six-point Likert type. The minimum score that can be obtained from the scale is 0, and the maximum score is 165.

    Measured: Baseline

  3. Paternal-Fetal Attachment Scale (PFAS)

    PFAS is a validated scale used to determine the level of paternal-fetal attachment. The responses are rated on a four-point Likert scale ranging from 1 to 4. The minimum possible total score is 23, and the maximum is 92.

    Measured: Baseline

  4. Fathers' Fear of Childbirth Scale (FFOC)

    The FFOC is a validated instrument used to determine fathers' level of fear related to childbirth. The responses are rated on a five-point Likert scale ranging from 1 to 5. The minimum possible total score is 17, and the maximum is 85.

    Measured: Baseline

Secondary outcomes (4)
  1. Prenatal Attachment Inventory (PAI)

    The PAI is a validated, explain thoughts, feelings, and situations experienced by woman during pregnancy and to determine the level of attachment to infant in prenatal period. Each item is of a four-point Likert type, with a score between 1 and 4. A minimum score of 21 and a maximum score of 84 can be obtained from the scale. Increase in the score obtained by pregnant indicates that level of attachment also increases.

    Measured: Week 5

  2. Wijma Delivery Expectancy/Experience Questionnaire version A (W-DEQ-A)

    The W-DEQ-A is a validated,to determine the level of birth fear experienced by pregnant women.Answers in the scale are numbered from 0 to 5 and are in a six-point Likert type. The minimum score that can be obtained from the scale is 0, and the maximum score is 165.

    Measured: Week 5

  3. Paternal-Fetal Attachment Scale (PFAS)

    PFAS is a validated scale used to determine the level of paternal-fetal attachment. The responses are rated on a four-point Likert scale ranging from 1 to 4. The minimum possible total score is 23, and the maximum is 92.

    Measured: Week 5

  4. Fathers' Fear of Childbirth Scale (FFOC)

    The FFOC is a validated instrument used to determine fathers' level of fear related to childbirth. The responses are rated on a five-point Likert scale ranging from 1 to 5. The minimum possible total score is 17, and the maximum is 85.

    Measured: Week 5

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted4 Dec 2025
  2. Study start26 Mar 2025
  3. Primary completion27 Mar 2026 (estimated)
  4. Study completion1 Apr 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
144 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07263750
Sponsor's protocol ID
OHU-DKH-SD-01
Status last verified
Jan 2026
First submitted
31 Jul 2025
Last updated
3 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ozbek H, Pinar SE. The effect of haptonomy applied to pregnant women on perceived stress, fear of childbirth, and prenatal attachment: randomized controlled experimental study. Curr Psychol. 2022 Jul 16:1-10. doi: 10.1007/s12144-022-03388-1. Online ahead of print.

    PubMed 35874964

Questions about this trial

What is this clinical trial studying?

A study testing Haptonomy in people with Fear of Childbirth and Prenatal Attachment, run by Nigde Omer Halisdemir University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 15 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nilüfer Tuğut, Prof. Dr. (+0905327754828, nlfrtugut@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prenatal Attachment Inventory (PAI) (time frame: Baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07263750, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in